alendronate has been researched along with Primary Ovarian Insufficiency in 1 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
Primary Ovarian Insufficiency: Cessation of ovarian function after MENARCHE but before the age of 40, without or with OVARIAN FOLLICLE depletion. It is characterized by the presence of OLIGOMENORRHEA or AMENORRHEA, elevated GONADOTROPINS, and low ESTRADIOL levels. It is a state of female HYPERGONADOTROPIC HYPOGONADISM. Etiologies include genetic defects, autoimmune processes, chemotherapy, radiation, and infections. The most commonly known genetic cause is the expansion of a CGG repeat to 55 to 199 copies in the 5' untranslated region in the X-linked FMR1 gene.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morgan Ortiz, F | 1 |
| Meza Mendoza, C | 1 |
| Beltrán Lugo, I | 1 |
| Caballero RodrÃguez, B | 1 |
| Contreras Soto, JO | 1 |
1 other study available for alendronate and Primary Ovarian Insufficiency
| Article | Year |
|---|---|
[Resistant ovary syndrome. Case report].
Topics: Adolescent; Alendronate; Bone Density Conservation Agents; Estrogens; Female; Hormone Replacement Th | 2011 |